EZEwelina Zygmunt

Ewelina Zygmunt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ewelina Zygmunt has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The impact of the SARS-CoV-2 infection on the risk of developing preeclampsia

    by Anna Kozłowska, Anna Korzeniowska, Karolina Gendek, Ilona Gąbka, Weronika Dalmata, Jan Dąbrowski, Ewelina Zygmunt-Siembida, Dariusz Chojęta

    Introduction and purpose: The COVID-19 pandemic has significantly affected the health, life and quality of life of many people around the world. It caused huge changes in the daily functioning of entire societies. Pregnant women are a unique group of people who are particularly at risk. They are accompanied by fear for their health, but also fear of the impact of the disease on their offspring. The pandemic has also caused new challenges for mothers-to-be that have not occurred so far. In this paper, we would like to present the current state of knowledge on the impact of SARS-CoV-2 infection on the risk of developing pre-eclampsia. State of knowledge:   We analyzed studies showing the impact of COVID-19 infection on the health of pregnant women, especially on the risk of developing pre-eclampsia. Data from many studies are contradictory. Some studies do not indicate a significant impact of coronavirus infection on the development of pre-eclampsia. Some of them confirm a higher incidence of pre-eclampsia in pregnant women with confirmed COVID-19 infection. Conclusions:   Despite the experience gained, there are still many unknowns. Thanks to research, we have more and more knowledge about the course of COVID-19 in pregnant women and its impact on their lives. Many observations are still needed to formulate clear conclusions about the impact of COVID-19 on the risk of developing pre-eclampsia. It is also necessary to continue to educate women, encourage compliance with the recommendations of doctors and the World Health Organization to prevent the spread of coronavirus.

  • Open Access

    A 69-year-old patient with Ogilvie’s syndrome –case report

    by Aleksandra Iwona Zimna, Hubert Wróblewski, Kinga Wróblewska, Błażej Tomasz Dziurowicz, Ewelina Zygmunt

    Ogilvie’s syndrome is a rare disease with a relatively high mortality rate (15%). It consists in significant distension of the colon, which is not caused by its obstruction. According to researchers, it usually occurs in patients with severe illness, injury, or after surgery The aim of the...


  • Open Access

    Modern methods of obesity treatment - review of the literature

    by Ewelina Zygmunt-Siembida, Hubert Wróblewska, Aleksandra Zimna, Kinga Wróblewska, Magdalena Kozdra, Laura Piasek, Aleksandra Osińska

    Introduction and aim of the study: Obesity is not only increases the risk of developing other diseases, but is itself a chronic disease. It is characterized by a lack of tendency to spontaneous resolution and a tendency to relapse. The growing number of patients facing obesity and its consequences prompts the search for newer and newer methods of its treatment. The aim of this paper is to discuss modern methods of obesity therapy, aimed at reducing the risk of its consequences, both health, psychological, social and economic. Methods and materials: This literature review is based on articles published in the PubMed database from 2016 to 2023, using the following phrases: "obesity risk factors", "obesity treatment", "diagnosis of obesity", "GLP -1 obesity". State of knowledg: We now know that obesity is a disease that needs to be treated. The goal of therapy is not only to achieve the target body weight, but also to reduce the risk of disease and improve the control of coexisting diseases. Conclusion: Obesity is a disease that requires interdisciplinary treatment based on behavioral therapy including changing the lifestyle to a healthier one, psychological support and pharmacological, and in some cases, surgical treatment.

  • Open Access

    The correlation between Yerba Mate and cancer - a review

    by Kinga Wróblewska, Hubert Wróblewski, Monika Zajączkowska, Bartosz Wójtowicz, Aleksandra Zimna, Ewelina Zygmunt-Siembida, Halina Piecewicz-Szczęsna

    Introduction and objective Yerba Mate (YM) is a popular drink obtained from the dried and ground leaves of the Ilex paraguariens. The beneficial effects of Yerba Mate on the cardiovascular system, lipid-lowering, anti-diabetic, hepatoprotective and stimulating properties are known, however, there are also reports supporting its toxicity, that the consumption of Yerba Mate may predispose to the development of cancer. The purpose of this article is to present and organize information on the correlation between drinking Yerba Mate and cancer. Review methods A review of the available literature was performed by searching the PubMed and Google Scholar databases using the following keywords: Yerba Mate and cancer, Yerba Mate. Abbreviated description of the state of knowledge Substances contained in Yerba Mate have a positive impact on the human body. They exert health-promoting effects, e.g. increasing HDL levels and enhancing the antioxidant effect. A particularly desirable effect of Yerba Mate is its modulating effect on the course of the carcinogenesis process. Current knowledge on this subject is not complete. There are no evidences that substances in Yerba Mate without other risk factors increase the risk of oesophageal cancer. It is worth emphasizing that the properties of the Yerba Mate components are related to the reduction of the development of metastases of other cancers. Summary Despite the carcinogenic PAHs contained in the YM extract, there is no clear evidence that drinking it alone, without taking into account the temperature of the drink, could predispose to the development of esophageal cancer. Many substances found in YM have a beneficial effect on the human body.


  • Open Access

    Gestational diabetes mellitus - pathogenesis, diagnosis, treatment and prognosis

    by Ewelina Zygmuny-Siembida, Hubert Wróblewski, Aleksandra Zimna, Kinga Wróblewska, Magdalena Kozdra, Laura Piasek, Aleksandra Osińska

    Gestational diabetes mellitus (GDM) is one of the most common complications of pregnancy. It is characterized by hyperglycemia resulting from impaired tissue sensitivity to insulin secreted by pancreatic beta cells. This is due to the action of hormones secreted by the placenta that oppose insulin. The incidence of gestational diabetes continues to increase, posing many potential risks to both mother and fetus. Importantly, these complications also have a long-term dimension. It has been proven that in adulthood, in children born from pregnancies complicated by gestational diabetes, the risk of developing obesity, type II diabetes and cardiovascular diseases increases. Their mothers are also at a similar risk. The main goal of treatment of gestational diabetes is to achieve normoglycaemia. Appropriate dietary management is recommended, and if this is not sufficient, insulin therapy should be initiated.


  • Open Access

    Modulators of CFTR protein function in the treatment of cystic fibrosis - a literature review

    by Dariusz Chojęta, Monika Mierzwa, Hubert Wróblewski, Aleksandra Zimna, Ewelina Zygmunt, Anna Kozłowska, Katarzyna Łysiak

    Cystic fibrosis (CF) is a multi-system genetic disease with an autosomal recessive inheritance mechanism. The breakthroughs in the therapy of patients with CF turned out to be modulators of CFTR protein function. These small-molecule substances, influencing the basic pathogenetic defect, became a model example of precise targeted therapy, thus showing a significant advantage over symptomatic treatment. For modulators of CFTR protein function, numerous therapeutic benefits have been demonstrated with an acceptable safety profile - improved lung function and reduced frequency of pulmonary exacerbations, reduced hospitalization rate, and disease-related improvement in quality of life. The use of these drugs changes the perception of CF from a fatal pediatric disease significantly shortening the life expectancy of patients into a chronic disease in young adults. The subject of further research interest is the development of alternative therapeutic strategies based on new modulators and gene therapy. The publication is a review of the literature and summarizes the current scientific reports on the effectiveness of the use of modulators of CFTR protein function in the treatment of cystic fibrosis.

  • Open Access

    Risk factors of developing inflammatory bowel diseases

    by Aleksandra Iwona Zimna, Hubert Wróblewski, Dariusz Chojęta, Ewelina Zygmunt, Anna Kozłowska

    Introduction: The pathogenesis of inflammatory bowel disease (IBD) is still unknown. It is known to be multi-factorial. The world is seeing an ever increasing number of new cases of these diseases. Ulcerative colitis and Crohn's disease are the main representatives of inflammatory bowel diseases. Aim: The aim of the study was to analyze risk factors for inflammatory bowel diseases. Materials and methods: The results were obtained on the basis of a questionnaire survey. Results: 95 people took part in the survey aged 16 to 72 years old. 35.8% were men and 64.2% were women. 78% lives in cites, only 22% are rural residents. 56.4% of them suffer from ulcerative colitis and 43.6% from Crohn's disease. 40.4% of respondents smoked cigarettes in the past, but currently only 12.6% are still struggling with the addiction. Only 4 people declare brushing their teeth after each meal. 18 people confirm the presence of NCDH in their families, 19 suffer from other autoimmune diseases at the same time. 2 people from among the respondents - also celiac disease. One person had Salmonella and Shigella infection. Conclusions: Due to the mutual cause-effect relationships between genetic predisposition and the influence of environmental factors, it is currently difficult to state which of the above factors plays a decisive role. Environmental factors that play a role in the etiopathogenesis of IBD include, first and foremost, the intestinal bacterial flora, diet, human environment and smoking. There is a clear tendency for the coexistence of autoimmune diseases in the group of patients with NCJ and a predisposition to the disease in the family. There is also a need to educate patients about the benefits of taking probiotics and taking care of proper eating habits. Key words: inflammatory bowel diseases, risk of developing the disease, irresponsible patient

  • Open Access

    Psychiatric manifestations of rheumatic diseases

    by Hubert Wróblewski, Dariusz Chojęta, Aleksandra Zimna, Ewelina Zygmunt, Anna Kozłowska, Monika Mierzwa, Kinga Wróblewska

    Introduction and purpose of the work: Rheumatic diseases are chronic diseases that cause symptoms in many systems of the human body. Their most common symptoms include pain and symptoms of arthritis, their deformities, fatigue, and malaise. The aim of the article is to present the symptoms and mental disorders occurring in the course of selected rheumatic diseases. State of knowledge: The psychological symptoms are characteristic of systemic lupus erythematosus. Specified is a form of lupus called NSPLE (neuropsychiatric systemic lupus erythematosus), which includes neuropsychiatric symptoms in the course of systemic lupus erythematosus. Psychiatric symptoms are also present in the course of other rheumatic diseases. Neuropsychiatric symptoms may affect up to 80% of patients with primary Sjogren's syndrome, with 50% to 80% ahead of diagnosis. It has been proven that systemic slcerosis causes microvascular damage, which may cause neuropsychiatric symptoms in the form of mood disorders, anxiety and cognitive disorders. In one study, 59% of patients with fibromyalgia experienced mania, which was more than twice as high as in the control group. Summary: In the course of all rheumatic diseases presented by us, there are symptoms and mental disorders. They are often mood, cognitive and sleep disturbances. It should be emphasized that the etiology of psychiatric symptoms is multifactorial.


  • Open Access

    How to treat acne in women with polycystic ovary syndrome (PCOS)? Review of the available literature

    by Ewelina Zygmunt, Hubert Wróblewski, Aleksandra Zimna, Dariusz Chojęta, Anna Kozłowska

    Acne vulgaris is one of the most common chronic skin diseases among people between 15 and 40 years of age.[i] It would seem that it is a typical disease of adolescence. However, it also very often affects adults. One of the most common causes of acne vulgaris in adult women is polycystic ovary syndrome (PCOS). The hyperandrogenism and metabolic disorders present in this syndrome may contribute to the formation of blackheads, pimples, and cysts on the face, chest and back. This article focuses on a review of current acne treatments associated with polycystic ovary syndrome. [i] Stern RS. Medication and medical service utilization for acne 1995-1998. J Am Acad Dermatol 2000; 43: 1042-1048  

  • Open Access

    Is schizophrenia just a mental illness? - The correlation between schizophrenia and cancer

    by Hubert Wróblewski, Dariusz Chojęta, Aleksandra Zimna, Ewelina Zygmunt, Kinga Wróblewska

    Introduction and purpose of the work:Schizophrenia is a mental illness that affects approximately 24 million people worldwide. It is characterized by hallucinations, most often auditory, delusions, blunted affect, and distortions of thought, such as echoes of thought and perception. There is a predisposition to more frequent diabetes, metabolic syndrome, hormonal disorders, cardiovascular diseases and respiratory diseases, even in patients not treated with antipsychotics. In connection with the above, the question may arise whether schizophrenia also predisposes to developing other diseases, such as cancer. The aim of this article is to present the relationship between the occurrence of schizophrenia and cancer. State of knowledge:There was no correlation between an increased incidence of lung cancer and schizophrenia, however, the analyzed studies were not homogeneous. In the case of breast cancer, data suggest a higher incidence of breast cancer among people with psychiatric disorders. In prostate cancer, a lower risk of developing the disease has been reported in patients with schizophrenia. It should be noted that despite the predisposition of people with schizophrenia to addiction to stimulants, low physical activity, the increase in the risk of cancer in some studies was not very high. Summary: It can be noticed that there is a correlation between the occurrence of schizophrenia and the predisposition to developing malignant neoplasms. Currently, hope is placed on their use in anti-cancer therapy.